Figure 1.
Kaplan-Meier survival. A: Kaplan-Meier overall survival for transarterial chemoembolization (TACE) alone and TACE + sorafenib; B: Kaplan-Meier progression-free survival for TACE alone and TACE + sorafenib.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.